No benefit from high-dose multivitamins seen for HIV patients receiving antiretroviral therapy
Tuesday, October 16, 2012 - 16:00
in Health & Medicine
A new study suggests that for HIV patients receiving highly active antiretroviral therapy (HAART) to treat HIV, there is no benefit from high- vs. standard-dose micronutrient supplementation -- and that, in fact, high-dose supplements may cause harm. The study is the first large randomized trial to look at how high-dose multivitamin supplementation affects clinical outcomes among people on HAART.